October 10th, 2024 “EURETINA-Brief”© Issue No. 301
Dear EURETINA Members, A very warm welcome to the October 10th, 2024 edition of EURETINA’s web-based digital periodical, “EURETINA Brief”. EURETINA are delighted to continue…
EURETINA’s
DIGITAL
NEWSLETTER
Featured Articles
1
October 10th, 2024
Latest News
October 10th, 2024 “EURETINA-Brief”© Issue No. 301
Dear EURETINA Members, A very warm welcome to the October 10th, 2024 edition of EURETINA’s…
CNGA3-associated ACHM displays stable foveal cone structure over time, presenting an attractive therapeutic opportunity for treatment.
Researchers at UCL Institute of Ophthalmology, University College London, and Moorfields Eye Hospital NHS Foundation…
Real world data from the treatment by voretigene neparvovec (Luxturna) of LCA2-RPE65 patients across 24 countries.
EURETINA Congress, Barcelona – Sept. 20th, 2024: Prof. M. Dominick Fischer, based at Nuffield Laboratory…
Roche supported by a real-world study with initial outcomes on faricimab at EURETINA Congress – treatment-naïve patients with nAMD and DME (VOYAGER Study).
Delegates at the EURETINA Congress in Barcelona (Sept. 20th 2024) have heard new outcome data…